Financials

News Discussions Technicals Seasonals

0NWK fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Valerio Therapeutics SA is a is a clinical-stage biotechnology company, which engages in the development of oncology drugs targeting tumor intracellular processes. The firm produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Jean Theron, Gilles Avenard, and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

0NWK has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company